Xilio Therapeutics Inc. (XLO)
0.71
-0.02 (-2.90%)
At close: Apr 03, 2025, 3:59 PM
0.72
1.04%
Pre-market: Apr 04, 2025, 04:12 AM EDT
Xilio Therapeutics Revenue
Xilio Therapeutics reported an annual revenue of $6.34M, reflecting a 0% growth. For the quarter ending December 31, 2024, Xilio Therapeutics generated $1.72M in revenue.
Revenue (ttm)
$6.34M
Revenue Growth
0%
Price / Sales Ratio
8.06
Revenue / Employee
$99.13K
Employees
64
Market Cap
36.9M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 6.34M | +Infinity% |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |